Skip to main content

Table 2 Joints involvement and pattern in the study groups

From: The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis

Outcome variables (n, %)

Group I (n = 20)

Group 1I (n = 20)

P

Arthritis pattern

Symmetrical polyarthritis

13 (65)

12 (60)

0.74

Oligo- or mono-arthritis

7 (35)

8 (40)

Ankle involvement

16 (80)

16 (80)

1.00

Knee involvement

7 (35)

6 (30)

0.74

Hip involvement

8 (40)

7 (35)

0.75

Wrist involvement

12 (60)

14 (70)

0.51

Elbow involvement

8 (40)

8 (40)

1.00

Shoulder involvement

10 (50)

8 (40)

0.52

MCP involvement

14 (70)

14 (70)

1.00

PIP involvement

13 (65)

14 (70)

0.74

  1. MCP metacarpophalangeal joint, PIP proximal interphalangeal joint, MTP metatarsophalangeal